GSK Wins FDA Approval for Blujepa, First New Oral Antibiotic for UTIs in Nearly 30 Years

GSK plc announced that the US Food and Drug Administration (FDA) has approved Blujepa (gepotidacin) for the treatment of female adults (≥40 kg...

March 26, 2025 | Wednesday | News
Sichuan Kelun-Biotech Secures Approval for First Radionuclide-Drug Conjugate (RDC) Clinical Trial in China

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company has received a clinical trial notice approving the inve...

March 26, 2025 | Wednesday | News
Nxera Pharma’s Partner Tempero Bio Launches Phase 2 Trial of TMP-301 for Alcohol Use Disorder

Nxera Pharma Co., Ltd. announces that its partner Tempero Bio, Inc. has initiated a Phase 2 trial of TMP-301, a potent, selective and orally available mGlu...

March 25, 2025 | Tuesday | News
Shanghai Junshi Biosciences' Toripalimab Receives NMPA Approval for First-Line Treatment of Metastatic Liver Cancer

Shanghai Junshi Biosciences Co., Ltd, a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization ...

March 24, 2025 | Monday | News
Rhythm Pharmaceuticals Receives Orphan Drug Designation for Setmelanotide in Japan for Acquired Hypothalamic Obesity

Rhythm Pharmaceuticals, Inc., a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendoc...

March 21, 2025 | Friday | News
FDA Clears Altesa BioSciences' IND for Vapendavir to Treat Rhinovirus Infections in COPD Patients

Altesa BioSciences, Inc., a clinical-stage pharmaceutical company dedicated to developing new treatments for viral infections in vulnerable populations, an...

March 21, 2025 | Friday | News
Signal12 Secures FDA Alignment for Phase 3 Trial of Pro-ocular™ in Ocular Graft-versus-Host Disease

 Signal12, Inc., a clinical-stage ophthalmic pharmaceutical company focused on first-of-a-kind patented technologies that enable existing drugs to act...

March 19, 2025 | Wednesday | News
Whitehawk Therapeutics Debuts New Identity, Advances ADC Portfolio

Whitehawk Therapeutics, Inc. formerly known as Aadi Bioscience, Inc., an oncology therapeutics company applying advanced technologies to establis...

March 19, 2025 | Wednesday | News
New Diagnostics for Schistosomiasis Receive JPY 780 Million Investment to Improve Global Health

Schistosomiasis is one of 21 NTDs that affects approximately 250 million people worldwide, with 90% of cases occurring in Africa. People become infect...

March 19, 2025 | Wednesday | News
HistoIndex Launches FibroSIGHT to Improve Fibrosis Assessment in MASH Patients

HistoIndex, a global leader in stain-free digital pathology solutions for managing fibrotic diseases, has announced the launch of their first Laboratory De...

March 19, 2025 | Wednesday | News
Life Molecular Imaging & St. Teresa’s Hospital Launch Neuraceq® in Hong Kong for Early Alzheimer’s Diagnosis

Life Molecular Imaging (LMI) and St. Teresa's Hospital are pleased to announce that Florbetaben (18F) Injection (brand name: Neuraceq®) will be av...

March 18, 2025 | Tuesday | News
Sanofi Accelerates Flu Vaccine Production for 2025-26 Season, Aligning with FDA-Selected Strains

Sanofi announced the immediate adoption of influenza strains selected by the US Food and Drug Administration (FDA) to advance the manufacturing and ...

March 17, 2025 | Monday | News
AbbVie’s Final Phase 3 MIRASOL Data Confirms 32% Reduced Risk of Death with ELAHERE in Platinum-Resistant Ovarian Cancer

Final data analysis from Phase 3 MIRASOL trial after 30.5-month median follow-up demonstrated 32% reduction in risk of death with E...

March 17, 2025 | Monday | News
Dr. Reddy’s Recalls Levetiracetam Injection in the U.S. Due to Mislabeled Infusion Bags

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as “D...

March 14, 2025 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close